HIF-2 alpha-induced upregulation of CD36 promotes the development of ccRCC

Meng Liao,Yiyu Li,Anhua Xiao,Qianlan Lu,Han Zeng,Hong Qin,Enze Zheng,Xiaoqing Luo,Lin Chen,Xiong Z. Ruan,Ping Yang,Yaxi Chen
DOI: https://doi.org/10.1016/j.yexcr.2022.113389
IF: 4.145
2022-01-01
Experimental Cell Research
Abstract:Clear cell renal cell carcinoma (ccRCC) is characterized by the abundance of lipid droplets and the activation of the hypoxia-inducible factor (HIF) signaling pathway. However, the lipid reprogramming induced by HIF signaling in ccRCC is not fully understood. In this study, we found that the fatty acid receptor CD36 was highly expressed in human ccRCC tissues and ccRCC cell lines. CD36 overexpression increased fatty acid uptake and lipid droplet formation, and enhanced the proliferation and migration of ccRCC cells in a DGAT1-dependent manner. In contrast, the disruption of endogenous CD36 showed the opposite effects. The upregulated expres-sion of CD36 in ccRCC was associated with hypoxia and HIF-2 alpha activation. Furthermore, we identified CD36 as a new target of the transcription factor HIF-2 alpha. The knockdown of CD36 in ccRCC cells reduced lipid accumulation and also blocked the tumor-promoting effects induced by HIF-2 alpha under hypoxia. Our findings suggest that hypoxia-dependent HIF-2 alpha promotes the remodeling of lipid metabolism and the malignant phenotype of ccRCC via CD36, providing a certain theoretical basis for clarifying the mechanism of ccRCC.
What problem does this paper attempt to address?